These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 35327661)
1. Alpha-Synuclein-Specific Naturally Occurring Antibodies Inhibit Aggregation In Vitro and In Vivo. Braczynski AK; Sevenich M; Gering I; Kupreichyk T; Agerschou ED; Kronimus Y; Habib P; Stoldt M; Willbold D; Schulz JB; Bach JP; Falkenburger BH; Hoyer W Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327661 [TBL] [Abstract][Full Text] [Related]
2. Alpha-Synuclein Autoimmune Decline in Prodromal Multiple System Atrophy and Parkinson's Disease. Folke J; Bergholt E; Pakkenberg B; Aznar S; Brudek T Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742998 [TBL] [Abstract][Full Text] [Related]
3. Autoimmune antibody decline in Parkinson's disease and Multiple System Atrophy; a step towards immunotherapeutic strategies. Brudek T; Winge K; Folke J; Christensen S; Fog K; Pakkenberg B; Pedersen LØ Mol Neurodegener; 2017 Jun; 12(1):44. PubMed ID: 28592329 [TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol-3,4,5-trisphosphate interacts with alpha-synuclein and initiates its aggregation and formation of Parkinson's disease-related fibril polymorphism. Choong CJ; Aguirre C; Kakuda K; Beck G; Nakanishi H; Kimura Y; Shimma S; Nabekura K; Hideshima M; Doi J; Yamaguchi K; Nakajima K; Wadayama T; Hayakawa H; Baba K; Ogawa K; Takeuchi T; Badawy SMM; Murayama S; Nagano S; Goto Y; Miyanoiri Y; Nagai Y; Mochizuki H; Ikenaka K Acta Neuropathol; 2023 May; 145(5):573-595. PubMed ID: 36939875 [TBL] [Abstract][Full Text] [Related]
5. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein. Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536 [TBL] [Abstract][Full Text] [Related]
6. Naturally occurring autoantibodies against α-synuclein rescues memory and motor deficits and attenuates α-synuclein pathology in mouse model of Parkinson's disease. Huang YR; Xie XX; Ji M; Yu XL; Zhu J; Zhang LX; Liu XG; Wei C; Li G; Liu RT Neurobiol Dis; 2019 Apr; 124():202-217. PubMed ID: 30481547 [TBL] [Abstract][Full Text] [Related]
7. 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model. Underwood R; Gannon M; Pathak A; Kapa N; Chandra S; Klop A; Yacoubian TA Acta Neuropathol Commun; 2021 Jan; 9(1):13. PubMed ID: 33413679 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of α-Synuclein Protein Levels by an Intracellular Single-Chain Antibody. Chen YH; Yu SJ; Wu KJ; Wang YS; Tsai HM; Liao LW; Chen S; Hsieh W; Chen H; Hsu SC; Chen ML; Hoffer BJ; Wang Y J Parkinsons Dis; 2020; 10(2):573-590. PubMed ID: 32176654 [TBL] [Abstract][Full Text] [Related]
9. DJ-1 Acts as a Scavenger of α-Synuclein Oligomers and Restores Monomeric Glycated α-Synuclein. Atieh TB; Roth J; Yang X; Hoop CL; Baum J Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680099 [TBL] [Abstract][Full Text] [Related]
10. Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein. Albus A; Gold M; Bach JP; Burg-Roderfeld M; Jördens M; Kirchhein Y; Kronimus Y; Mengel D; Zerr I; Dodel R PLoS One; 2018; 13(8):e0202954. PubMed ID: 30157279 [TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidylcholine acyltransferase 1 promotes pathology and toxicity in two distinct cell-based alpha-synuclein models. Nicholatos JW; Tran D; Liu Y; Hirst WD; Weihofen A Neurosci Lett; 2022 Feb; 772():136491. PubMed ID: 35108590 [TBL] [Abstract][Full Text] [Related]
12. Trehalose does not improve neuronal survival on exposure to alpha-synuclein pre-formed fibrils. Redmann M; Wani WY; Volpicelli-Daley L; Darley-Usmar V; Zhang J Redox Biol; 2017 Apr; 11():429-437. PubMed ID: 28068606 [TBL] [Abstract][Full Text] [Related]